These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Documentation only for EpiPen]. Kwant M; Ganlöv K Lakartidningen; 2008 Oct 8-14; 105(41):2865. PubMed ID: 19013848 [No Abstract] [Full Text] [Related]
25. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. Järvinen KM; Sicherer SH; Sampson HA; Nowak-Wegrzyn A J Allergy Clin Immunol; 2008 Jul; 122(1):133-8. PubMed ID: 18547626 [TBL] [Abstract][Full Text] [Related]
26. Managing childhood food allergies and anaphylaxis. Hu W; Kemp A Aust Fam Physician; 2005; 34(1-2):35-8. PubMed ID: 15727356 [TBL] [Abstract][Full Text] [Related]
27. Epinephrine for anaphylaxis: underutilized and unavailable. Dudley LS; Mansour MI; Merlin MA West J Emerg Med; 2015 May; 16(3):385-7. PubMed ID: 25987911 [No Abstract] [Full Text] [Related]
28. [The vast majority of drug committees recommend Anapen]. Larsson I; Ferrándiz R Lakartidningen; 2008 Oct 8-14; 105(41):2865. PubMed ID: 19013849 [No Abstract] [Full Text] [Related]
29. [Rapid and safe use of adrenaline auto-injectors: We have a problem!]. García-Magán C; Giráldez Montero JM; Moure-González JD; Rodríguez-Núñez A An Pediatr (Engl Ed); 2020 Jun; 92(6):388-389. PubMed ID: 31864845 [No Abstract] [Full Text] [Related]
30. Safety and efficacy of subcutaneous adrenaline as a treatment for anaphylactic reactions to polyvalent antivenom. Kularatne SA; Gawarammana IB; Kumarasiri PV; Senanayake N; Dissanayake WP; Ariyasena H Ceylon Med J; 2003 Dec; 48(4):148-9. PubMed ID: 15125413 [No Abstract] [Full Text] [Related]
31. Pitfalls in the use of epinephrine for anaphylaxis: patient and provider opportunities for improvement. Cohen MB; Saunders SS; Wise SK; Nassif S; Platt MP Int Forum Allergy Rhinol; 2017 Mar; 7(3):276-286. PubMed ID: 27869359 [TBL] [Abstract][Full Text] [Related]
32. In brief: Auvi-Q--a new epinephrine auto-injector. Med Lett Drugs Ther; 2013 Feb; 55(1410):13. PubMed ID: 23459456 [No Abstract] [Full Text] [Related]
34. Applying prevention concepts to anaphylaxis: A call for worldwide availability of adrenaline auto-injectors. Tanno LK; Simons FER; Sanchez-Borges M; Cardona V; Moon HB; Calderon MA; Sisul JC; Muraro A; Casale T; Demoly P; Clin Exp Allergy; 2017 Sep; 47(9):1108-1114. PubMed ID: 28856836 [No Abstract] [Full Text] [Related]
35. Severe myocardial ischemia after concentrated epinephrine use for the treatment of anaphylaxis: Kounis syndrome or epinephrine effect? Izgi C; Cevik C; Nugent K Heart Lung; 2010; 39(2):160-3. PubMed ID: 20207277 [No Abstract] [Full Text] [Related]
37. Survey of the use of epinephrine (adrenaline) for anaphylaxis by junior hospital doctors. Jose R; Clesham GJ Postgrad Med J; 2007 Sep; 83(983):610-1. PubMed ID: 17823230 [TBL] [Abstract][Full Text] [Related]
38. Medical emergencies: auto-injector confusion. Bryant C; Umar G Br Dent J; 2014 Jul; 217(2):54. PubMed ID: 25060429 [No Abstract] [Full Text] [Related]
39. Are dispensing patterns for epinephrine autoinjectors age-appropriate in children? Tam H; Simons FER; Simons E J Allergy Clin Immunol Pract; 2017; 5(5):1435-1437.e1. PubMed ID: 28757368 [No Abstract] [Full Text] [Related]
40. Questions and answers about anaphylaxis. An information sheet for patients. Ellis AK; Day JH CMAJ; 2003 Aug; 169(4):312. PubMed ID: 12947961 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]